3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
1
Metabolic Syndrome
1
Heart Failure
1
Cardiovascular Diseases
1
Interventions
xinmailong
1
pembrolizumab
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Sugars
1
Pyruvic Acid
1
Linseed Oil
1
Gonadotropin-Releasing Hormone
1
Atorvastatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Cardiovascular Diseases
×
Pyruvic Acid
×
Clear all
NCT06645691
2024-12-06
POLARIC-13
National Heart Centre Singapore
Phase 2
Recruiting
200 enrolled